Dashboard
Strong Long Term Fundamental Strength with a 18.02% CAGR growth in Operating Profits
- Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 27.59
- The company has been able to generate a Return on Capital Employed (avg) of 12.29% signifying high profitability per unit of total capital (equity and debt)
With ROE of 16.65%, it has a attractive valuation with a 1.43 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
JPY 4,480,202 Million (Large Cap)
9.00
NA
0.00%
-0.10
15.81%
1.65
Total Returns (Price + Dividend) 
Otsuka Holdings Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News

Otsuka Holdings Hits Day Low at JPY 8,018 Amid Price Pressure
Otsuka Holdings Co. faced a significant stock price decline today, reaching an intraday low. Despite this, the company has shown a positive monthly return and maintains strong long-term fundamentals, including a solid growth rate in operating profits and robust financial health metrics.
Read More
Otsuka Holdings Hits Day Low at JPY 7,756 Amid Price Pressure
Otsuka Holdings Co. faced a notable stock decline on October 14, 2025, reaching an intraday low. The company's recent performance contrasts with the Japan Nikkei 225, reflecting a downward trend over various timeframes. However, Otsuka maintains a strong long-term outlook with solid financial metrics and growth potential.
Read More
Otsuka Holdings Hits Day High with Strong 3.92% Intraday Surge
Otsuka Holdings Co. has demonstrated notable stock performance, reaching an intraday high of JPY 8,554.00 on October 7, 2025. The company has shown resilience over three and five years, with significant returns, while maintaining strong financial metrics and a large market capitalization in the Pharmaceuticals & Biotechnology sector.
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Foreign Institutions
Held in 0 Schemes (0%)
Held by 4 Foreign Institutions (0.31%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
YoY Growth in quarter ended Jun 2025 is 1.44% vs 18.07% in Jun 2024
YoY Growth in quarter ended Jun 2025 is 183.33% vs -25.16% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 15.42% vs 16.14% in Dec 2023
YoY Growth in year ended Dec 2024 is 176.71% vs -8.58% in Dec 2023






